Julia A. Hasler

2.4k total citations
49 papers, 1.8k citations indexed

About

Julia A. Hasler is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Julia A. Hasler has authored 49 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 13 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Julia A. Hasler's work include Pharmacogenetics and Drug Metabolism (23 papers), Drug Transport and Resistance Mechanisms (10 papers) and Glutathione Transferases and Polymorphisms (7 papers). Julia A. Hasler is often cited by papers focused on Pharmacogenetics and Drug Metabolism (23 papers), Drug Transport and Resistance Mechanisms (10 papers) and Glutathione Transferases and Polymorphisms (7 papers). Julia A. Hasler collaborates with scholars based in Zimbabwe, United States and Sweden. Julia A. Hasler's co-authors include Collen Masimirembwa, Magnus Ingelman‐Sundberg, Yogeshkumar S. Naik, Leif Bertilsson, Inger Johansson, Tashinga E. Bapiro, Tapiwanashe Magwere, Stanley Mukanganyama, Jane Sayi and Collet Dandara and has published in prestigious journals such as The Lancet, Nucleic Acids Research and The EMBO Journal.

In The Last Decade

Julia A. Hasler

49 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia A. Hasler Zimbabwe 25 968 499 435 212 168 49 1.8k
Véronique Descatoire France 31 1.2k 1.3× 686 1.4× 614 1.4× 128 0.6× 229 1.4× 56 2.8k
Irma Meijerman Netherlands 25 808 0.8× 687 1.4× 667 1.5× 148 0.7× 162 1.0× 52 2.1k
Olavi Pelkonen Finland 29 1.3k 1.3× 673 1.3× 560 1.3× 239 1.1× 294 1.8× 68 2.7k
Alain Berson France 36 1.3k 1.3× 1.3k 2.5× 456 1.0× 139 0.7× 202 1.2× 59 3.9k
T. Kamataki Japan 9 989 1.0× 675 1.4× 424 1.0× 108 0.5× 159 0.9× 13 1.7k
David M. Stresser United States 29 1.4k 1.4× 822 1.6× 630 1.4× 143 0.7× 198 1.2× 54 2.5k
Donald S. Davies United Kingdom 31 1.3k 1.3× 923 1.8× 709 1.6× 159 0.8× 213 1.3× 92 3.0k
Jean‐Charles Gautier France 27 1.2k 1.3× 852 1.7× 646 1.5× 119 0.6× 239 1.4× 60 2.8k
Roger J. Price United Kingdom 30 1.3k 1.3× 815 1.6× 558 1.3× 199 0.9× 193 1.1× 95 2.6k
Lysiane Richert France 33 1.1k 1.1× 810 1.6× 668 1.5× 154 0.7× 137 0.8× 129 3.1k

Countries citing papers authored by Julia A. Hasler

Since Specialization
Citations

This map shows the geographic impact of Julia A. Hasler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia A. Hasler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia A. Hasler more than expected).

Fields of papers citing papers by Julia A. Hasler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia A. Hasler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia A. Hasler. The network helps show where Julia A. Hasler may publish in the future.

Co-authorship network of co-authors of Julia A. Hasler

This figure shows the co-authorship network connecting the top 25 collaborators of Julia A. Hasler. A scholar is included among the top collaborators of Julia A. Hasler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia A. Hasler. Julia A. Hasler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schulte, Dorothea, Michael Kiebler, Julia A. Hasler, et al.. (2019). Choroid plexus‐derived miR‐204 regulates the number of quiescent neural stem cells in the adult brain. The EMBO Journal. 38(17). e100481–e100481. 54 indexed citations
2.
Matlin, Stephen A., et al.. (2008). Signposts to research for health. The Lancet. 372(9649). 1521–1522. 3 indexed citations
3.
IJsselmuiden, Carel, Stephen A. Matlin, Julia A. Hasler, et al.. (2008). From Mexico to Mali: a new course for global health. The Lancet. 371(9607). 91–93. 15 indexed citations
4.
Bapiro, Tashinga E., et al.. (2005). Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans. European Journal of Clinical Pharmacology. 61(10). 755–761. 32 indexed citations
5.
Hayeshi, Rose, Stanley Mukanganyama, Banasri Hazra, Berhanu Abegaz, & Julia A. Hasler. (2004). The interaction of selected natural products with human recombinant glutathione transferases. Phytotherapy Research. 18(11). 877–883. 22 indexed citations
6.
Mukanganyama, Stanley, Christian C. Figueroa, Julia A. Hasler, & Hermann M. Niemeyer. (2003). Effects of DIMBOA on detoxification enzymes of the aphid Rhopalosiphum padi (Homoptera: aphididae). Journal of Insect Physiology. 49(3). 223–229. 61 indexed citations
7.
Bapiro, Tashinga E., Tommy B. Andersson, Charlotta Otter, Julia A. Hasler, & Collen Masimirembwa. (2002). Cytochrome P 450 1A1/2 induction by antiparasitic drugs: dose-dependent increase in ethoxyresorufin O-deethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cells. European Journal of Clinical Pharmacology. 58(8). 537–542. 24 indexed citations
8.
Dandara, Collet, Jane Sayi, Collen Masimirembwa, et al.. (2002). Genetic Polymorphism of Cytochrome P450 1A1 (CYP1A1) and Glutathione Transferases (M1, T1 and P1) among Africans. Clinical Chemistry and Laboratory Medicine (CCLM). 40(9). 952–7. 47 indexed citations
9.
Magwere, Tapiwanashe, Yogeshkumar S. Naik, & Julia A. Hasler. (1997). Effects of Chloroquine Treatment on Antioxidant Enzymes in Rat Liver and Kidney. Free Radical Biology and Medicine. 22(1-2). 321–327. 112 indexed citations
10.
Masimirembwa, Collen, Lars L. Gustafsson, Marja-Liisa Dahl, Yakoub Aden Abdi, & Julia A. Hasler. (1996). Lack of effect of chloroquine on the debrisoquine (CYP2D6) and S‐mephenytoin (CYP2C19) hydroxylation phenotypes. British Journal of Clinical Pharmacology. 41(4). 344–346. 18 indexed citations
11.
Masimirembwa, Collen, Leif Bertilsson, Inger Johansson, Julia A. Hasler, & Magnus Ingelman‐Sundberg. (1995). Phenotyping and genotyping of S-mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe*. Clinical Pharmacology & Therapeutics. 57(6). 656–661. 68 indexed citations
12.
Masimirembwa, Collen, et al.. (1995). Low CYP1A2 activity in rural Shona children of Zimbabwe*. Clinical Pharmacology & Therapeutics. 57(1). 25–31. 18 indexed citations
13.
Hasler, Julia A., Inger Johansson, & Collen Masimirembwa. (1995). Inhibitory effects of antiparasitic drugs on cytochrome P450 2D6. European Journal of Clinical Pharmacology. 48(1). 35–8. 32 indexed citations
14.
Masimirembwa, Collen & Julia A. Hasler. (1994). Characterisation of praziquantel metabolism by rat liver microsomes using cytochrome P450 inhibitors. Biochemical Pharmacology. 48(9). 1779–1783. 35 indexed citations
15.
Hasler, Julia A., Greg R. Harlow, Grażyna D. Szklarz, et al.. (1994). Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity.. Molecular Pharmacology. 46(2). 338–345. 46 indexed citations
16.
Masimirembwa, Collen, Yogeshkumar S. Naik, & Julia A. Hasler. (1993). Effects of phenobarbital and 3-methylcholanthrene pretreatment on the pharmacokinetics of praziquantel in rats. European Journal of Drug Metabolism and Pharmacokinetics. 18(3). 261–264. 7 indexed citations
17.
Masimirembwa, Collen, Inger Johansson, Julia A. Hasler, & Magnus Ingelman‐Sundberg. (1993). Genetic polymorphism of cytochrome P450 CYP2D6 in Zimbabwean population. Pharmacogenetics. 3(6). 275–280. 50 indexed citations
18.
Groopman, John D., et al.. (1993). Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans.. Environmental Health Perspectives. 99. 107–113. 76 indexed citations
19.
Chetsanga, Christopher J., et al.. (1990). The effect of schistosomiasis on the covalent binding of 2-acetylaminofluorene to mouse liver macromolecules in vivo and in vitro. Biochemical Pharmacology. 40(2). 379–382. 3 indexed citations
20.
Pettit, George R., John A. Rideout, & Julia A. Hasler. (1990). Isolation of geodiatoxins 2–4 from the marine sponge Geodia mesotriaena. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 96(2). 305–306. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026